Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

PHASE4CompletedINTERVENTIONAL
Enrollment

1,571

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
HIV Infections
Interventions
DRUG

Atazanavir

400 mg taken orally daily

DRUG

Didanosine (enteric-coated)

400 mg taken orally daily

DRUG

Efavirenz

600 mg taken orally daily

DRUG

Emtricitabine

200 mg taken orally daily

DRUG

Emtricitabine/Tenofovir disoproxil fumarate

200 mg/300 mg taken orally once daily

DRUG

Lamivudine/Zidovudine

150 mg/300 mg taken orally twice daily

Trial Locations (42)

2092

Wits HIV CRS, Johannesburg

4001

Durban Adult HIV CRS, Durban

10003

Beth Israel Medical Center, New York

10011

Cornell CRS, New York

10016

NY Univ. HIV/AIDS CRS, New York

10032

HIV Prevention & Treatment CRS, HVTN 722 West 168th Street MSPH Bldg.

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

27514

University of North Carolina, Chapel Hill

Wake County Health and Human Services Clinical Research Site, Chapel Hill

27710

Duke University Medical Center, Durham

37204

Vanderbilt Therapeutics CRS, Nashville

43210

The Ohio State Univ. AIDS CRS, Columbus

50200

Chiang Mai Univ. ACTG CRS, P.O. Box 80

60612

Cook County Hospital Core Center, Chicago

411026

Dr. Kotnis Dispensary, Pune

600113

YRG CARE Medical Ctr., VHS Chennai CRS, Rajiv Gandhi Salai Taramani

90033-1079

University of Southern California, Los Angeles

90095-1793

UCLA CARE Center CRS, Los Angeles

90502-2052

Harbor General/UCLA, Torrance

Unknown

Univ. of Colorado Health Sciences Center, Denver, Denver

University of Texas, Southwestern Medical Center, Dallas

Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Manguinhos

NARI Pune CRS, Pune

NARI Clinic at NIV CRS, Maharashtra State

College of Med. JHU CRS, P.O. Box 1131

University of North Carolina Lilongwe CRS, Mzimba Road

Asociacion Civil Impacta Salud y Educacion - Miraf CRS, Barranco

San Miguel CRS, San Miguel

UZ-Parirenyatwa CRS, AIDS Research Unit P.O. Box A178

96816-2396

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

60611-3015

Northwestern University, Chicago

60612-3806

Rush-Presbyterian/St. Lukes (Chicago), Chicago

55455-0392

University of Minnesota, Minneapolis

63108-2138

Washington University (St. Louis), St Louis

14642-0001

Community Health Network, Inc., Rochester

Univ. of Rochester ACTG CRS, Rochester

45267-0405

University of Cincinnati, Cincinnati

02906

Stanley Street Treatment and Resource, Providence

The Miriam Hosp. ACTG CRS, Providence

77555-0435

University of Texas, Galveston, Galveston

91350-200

Hospital Nossa Senhora da Conceicao, Porto Alegre

HT-6110

Les Centres GHESKIO CRS, Bicentenaire

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK

NCT00084136 - Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings | Biotech Hunter | Biotech Hunter